Pharmaceutical industry
The latest news relating to the pharmaceuticals industry, including regulation, litigation, business news and relevant industrial and academic research, from the Royal Society of Chemistry's magazine, Chemistry World
-
Whitepaper
Optimise drug discovery: predicting transporter-mediated drug interactions
Learn how in vitro models, biomarkers and modelling can improve prediction of drug interactions and toxicity – reducing false positives and unnecessary clinical studies
-
Business
Free energy methods and digital transformation of drug discovery
Synergistic application of AI-based generative chemistry and free energy methods streamlines molecule discovery and optimisation
-
Opinion
Polymorphs matter – especially when they might disappear
Disappearing polymorphs offer a fascinating example of the dark arts of crystallisation
-
News
Fears grow over the future of mRNA vaccine research in the US
Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad
-
Business
Acceptable levels of (epi)genetic engineering
Amplifying or silencing genes may be preferable to permanently changing genetic code
-
Opinion
The value of good software extends beyond its cost
Whether third-party or built in-house, thoughtful design and implementation can improve workflows and make science more inclusive
-
Business
Government reduces UK Reach fees by ‘£40 million’
Registration fees for most chemicals reduced, but uncertainty remains over safety data requirements
-
Business
Epigenetic editors enter clinical trials
New wave of precision medicines amplify or silence genes, without altering genetic code
-
Opinion
Trump’s tariff stand-off
Piling cost and complexity to stretched global supply chains will hit industries hard
-
Business
Trump’s new tariffs threaten the chemicals sector
Broad and high tariffs could mean severe job losses and supply chain disruption for chemistry-using industries
-
Business
J&J’s third talc bankruptcy settlement attempt denied
Company says it will return to courts to fight talc cancer claims
-
Business
US regulatory chief’s resignation raises alarms in biotech industry
FDA vaccines and biologicals centre director, Peter Marks, clashed with health secretary Robert F Kennedy Jr
-
Opinion
Welcome to the MegaPharm target selection and project resourcing meeting
Overheard recently in a seminar room near you…
-
Opinion
Weight loss drug supply races
With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of drugs
-
Business
Ending of US weight-loss drug shortages prompts compounder complaints
Decision ends pharmacies’ permission to prepare versions of GLP-1 hormone mimics
-
Opinion
Why companies are rushing to flatter Trump
Pharma firms are among many pausing diversity programmes and promising domestic investment
-
Business
New Trump tariffs worry North American chemical industries
High duties on imports from Canada, Mexico and China raise problems for international supply chains
-
Opinion
Fluorine makes you an offer you can’t refuse
What might we do if we had a new, electron-donating equivalent element?
-
Research
Generative AI pipeline creates promising antimicrobial peptides
AI model extrapolates beyond training data to predict diverse antimicrobial structures
-
Business
New type of painkiller approved in US
Sodium channel blocker prevents nerves transmitting pain signals